Alphen A.D. Rijn, Netherlands

Marieke Griffioen


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Alphen aan den Rijn, NL (2013)
  • Alphen a/d Rijn, NL (2016 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marieke Griffioen in Cancer Treatment

Introduction

Marieke Griffioen is a prominent inventor hailing from Alphen a/d Rijn, Netherlands. With a focus on cancer research, she has made significant strides in the field with her innovative inventions. To date, Griffioen holds three patents that showcase her commitment to advancing medical science and improving patient outcomes.

Latest Patents

Griffioen's latest patents include groundbreaking work on PRAME derived peptides and immunogenic compositions. These inventions relate to peptides that are no more than 100 amino acids long, containing at least 19 contiguous amino acids derived from the human PRAME protein. Her innovation emphasizes the importance of including at least one HLA class II epitope and one HLA class I epitope from the human PRAME protein sequence. These peptides are intended for use as a medicament in the treatment and/or prevention of cancer, highlighting Griffioen's dedication to addressing critical health challenges in oncology.

Career Highlights

Marieke Griffioen is associated with the Leiden University Medical Center (LUMC), where she engages in groundbreaking research. Her work is not only a testament to her expertise but also reflects her passion for using science to benefit society. Throughout her career, she has continuously sought to harness the potential of immunotherapeutic approaches to combat cancer.

Collaborations

Griffioen's innovation journey is complemented by her collaboration with esteemed colleagues, including Jan Kessler and Jan Wouter Drijfhout. Working alongside such talented professionals enhances her research capabilities and contributes to the pooling of knowledge necessary for pioneering new medical solutions.

Conclusion

In summary, Marieke Griffioen stands out as a remarkable inventor in the realm of cancer treatment. With her significant contributions through patents, particularly focusing on PRAME derived peptides, she is paving the way for innovative medical therapies. Her career at the Leiden University Medical Center and collaborations with fellow researchers exemplify her determination to improve patients' lives through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…